Alzheimer's disease is a progressive and incurable disease whose preva
lence increases dramatically with age. A biochemical marker for monito
ring the onset and progression of the disease would be a valuable tool
for disease management. In addition, such a marker might be used as a
n end point in clinical intervention protocols. Here we provide eviden
ce that the soluble form of the iron binding protein p97 is found in e
levated amounts in the serum of Alzheimer's patients compared with hea
lthy controls. This biochemical marker has the potential for identifyi
ng subjects afflicted with the disease and possibly for monitoring the
onset and longitudinal progression of the disease.